T 1217/12 (Extending the duration of on-time in dopamin replacement therapy/MOTAC) of 07.06.2018
- European Case Law Identifier
- ECLI:EP:BA:2018:T121712.20180607
- Date of decision
- 7 June 2018
- Case number
- T 1217/12
- Petition for review of
- -
- Application number
- 01976536.1
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- TREATMENT OF MOTOR FLUCTUATIONS WITH 5-HYDROXYTRYPTAMINE 1A RECEPTOR ACTIVITY ENHANCING COMPOUNDS
- Applicant name
- Motac Neuroscience Limited
- Opponent name
- Abbott Healthcare Products B.V.
Merz Pharma GmbH & Co. KGaA - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention R 100(1)European Patent Convention R 84(1)
- Keywords
- Lapse of patent in all designated states - continuation of appeal proceedings (no)
- Catchword
- -
- Cited cases
- T 0708/01
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal proceedings are terminated.